Cargando…

Longitudinal associations between marine omega-3 supplement users and coronary heart disease in a UK population-based cohort

OBJECTIVES: Assess the association between marine omega-3 polyunsaturated fatty acid (n-3 PUFA) intake from supplements, mainly cod liver oil, and coronary heart disease (CHD) mortality. DESIGN: Prospective cohort study, with three exposure measurements over 22 years. SETTING: Norfolk-based European...

Descripción completa

Detalles Bibliográficos
Autores principales: Lentjes, Marleen A H, Keogh, Ruth H, Welch, Ailsa A, Mulligan, Angela A, Luben, Robert N, Wareham, Nicholas J, Khaw, Kay-Tee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5652534/
https://www.ncbi.nlm.nih.gov/pubmed/29030414
http://dx.doi.org/10.1136/bmjopen-2017-017471
_version_ 1783273076471889920
author Lentjes, Marleen A H
Keogh, Ruth H
Welch, Ailsa A
Mulligan, Angela A
Luben, Robert N
Wareham, Nicholas J
Khaw, Kay-Tee
author_facet Lentjes, Marleen A H
Keogh, Ruth H
Welch, Ailsa A
Mulligan, Angela A
Luben, Robert N
Wareham, Nicholas J
Khaw, Kay-Tee
author_sort Lentjes, Marleen A H
collection PubMed
description OBJECTIVES: Assess the association between marine omega-3 polyunsaturated fatty acid (n-3 PUFA) intake from supplements, mainly cod liver oil, and coronary heart disease (CHD) mortality. DESIGN: Prospective cohort study, with three exposure measurements over 22 years. SETTING: Norfolk-based European Prospective Investigation into Cancer (EPIC-Norfolk, UK). PARTICIPANTS: 22 035 men and women from the general population, 39–79 years at recruitment. EXPOSURE: Supplement use was assessed in three questionnaires (1993–1998; 2002–2004; 2004–2011). Participants were grouped into non-supplement users (NSU), n-3 PUFA supplement users (SU+n3) and non–n-3 PUFA supplement users (SU-n3). Cox regression adjusted for time-point specific variables: age, smoking, prevalent illnesses, body mass index, alcohol consumption, physical activity and season and baseline assessments of sex, social class, education and dietary intake (7-day diet diary). PRIMARY AND SECONDARY OUTCOME MEASURES: During a median of 19-year follow-up, 1562 CHD deaths were registered for 22 035 included participants. RESULTS: Baseline supplement use was not associated with CHD mortality, but baseline food and supplement intake of n-3 PUFA was inversely associated with CHD mortality after adjustment for fish consumption. Using time-varying covariate analysis, significant associations were observed for SU+n3 (HR: 0.74, 95% CI 0.66 to 0.84), but not for SU-n3 versus NSU. In further analyses, the association for SU+n3 persisted in those who did not take other supplements (HR: 0.83, 95% CI 0.71 to 0.97). Those who became SU+n3 over time or were consistent SU+n3 versus consistent NSU had a lower hazard of CHD mortality; no association with CHD was observed in those who stopped using n-3 PUFA-containing supplements. CONCLUSIONS: Recent use of n-3 PUFA supplements was associated with a lower hazard of CHD mortality in this general population with low fish consumption. Residual confounding cannot be excluded, but the findings observed may be explained by postulated biological mechanisms and the results were specific to SU+n3.
format Online
Article
Text
id pubmed-5652534
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-56525342017-10-27 Longitudinal associations between marine omega-3 supplement users and coronary heart disease in a UK population-based cohort Lentjes, Marleen A H Keogh, Ruth H Welch, Ailsa A Mulligan, Angela A Luben, Robert N Wareham, Nicholas J Khaw, Kay-Tee BMJ Open Epidemiology OBJECTIVES: Assess the association between marine omega-3 polyunsaturated fatty acid (n-3 PUFA) intake from supplements, mainly cod liver oil, and coronary heart disease (CHD) mortality. DESIGN: Prospective cohort study, with three exposure measurements over 22 years. SETTING: Norfolk-based European Prospective Investigation into Cancer (EPIC-Norfolk, UK). PARTICIPANTS: 22 035 men and women from the general population, 39–79 years at recruitment. EXPOSURE: Supplement use was assessed in three questionnaires (1993–1998; 2002–2004; 2004–2011). Participants were grouped into non-supplement users (NSU), n-3 PUFA supplement users (SU+n3) and non–n-3 PUFA supplement users (SU-n3). Cox regression adjusted for time-point specific variables: age, smoking, prevalent illnesses, body mass index, alcohol consumption, physical activity and season and baseline assessments of sex, social class, education and dietary intake (7-day diet diary). PRIMARY AND SECONDARY OUTCOME MEASURES: During a median of 19-year follow-up, 1562 CHD deaths were registered for 22 035 included participants. RESULTS: Baseline supplement use was not associated with CHD mortality, but baseline food and supplement intake of n-3 PUFA was inversely associated with CHD mortality after adjustment for fish consumption. Using time-varying covariate analysis, significant associations were observed for SU+n3 (HR: 0.74, 95% CI 0.66 to 0.84), but not for SU-n3 versus NSU. In further analyses, the association for SU+n3 persisted in those who did not take other supplements (HR: 0.83, 95% CI 0.71 to 0.97). Those who became SU+n3 over time or were consistent SU+n3 versus consistent NSU had a lower hazard of CHD mortality; no association with CHD was observed in those who stopped using n-3 PUFA-containing supplements. CONCLUSIONS: Recent use of n-3 PUFA supplements was associated with a lower hazard of CHD mortality in this general population with low fish consumption. Residual confounding cannot be excluded, but the findings observed may be explained by postulated biological mechanisms and the results were specific to SU+n3. BMJ Publishing Group 2017-10-13 /pmc/articles/PMC5652534/ /pubmed/29030414 http://dx.doi.org/10.1136/bmjopen-2017-017471 Text en © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/
spellingShingle Epidemiology
Lentjes, Marleen A H
Keogh, Ruth H
Welch, Ailsa A
Mulligan, Angela A
Luben, Robert N
Wareham, Nicholas J
Khaw, Kay-Tee
Longitudinal associations between marine omega-3 supplement users and coronary heart disease in a UK population-based cohort
title Longitudinal associations between marine omega-3 supplement users and coronary heart disease in a UK population-based cohort
title_full Longitudinal associations between marine omega-3 supplement users and coronary heart disease in a UK population-based cohort
title_fullStr Longitudinal associations between marine omega-3 supplement users and coronary heart disease in a UK population-based cohort
title_full_unstemmed Longitudinal associations between marine omega-3 supplement users and coronary heart disease in a UK population-based cohort
title_short Longitudinal associations between marine omega-3 supplement users and coronary heart disease in a UK population-based cohort
title_sort longitudinal associations between marine omega-3 supplement users and coronary heart disease in a uk population-based cohort
topic Epidemiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5652534/
https://www.ncbi.nlm.nih.gov/pubmed/29030414
http://dx.doi.org/10.1136/bmjopen-2017-017471
work_keys_str_mv AT lentjesmarleenah longitudinalassociationsbetweenmarineomega3supplementusersandcoronaryheartdiseaseinaukpopulationbasedcohort
AT keoghruthh longitudinalassociationsbetweenmarineomega3supplementusersandcoronaryheartdiseaseinaukpopulationbasedcohort
AT welchailsaa longitudinalassociationsbetweenmarineomega3supplementusersandcoronaryheartdiseaseinaukpopulationbasedcohort
AT mulliganangelaa longitudinalassociationsbetweenmarineomega3supplementusersandcoronaryheartdiseaseinaukpopulationbasedcohort
AT lubenrobertn longitudinalassociationsbetweenmarineomega3supplementusersandcoronaryheartdiseaseinaukpopulationbasedcohort
AT warehamnicholasj longitudinalassociationsbetweenmarineomega3supplementusersandcoronaryheartdiseaseinaukpopulationbasedcohort
AT khawkaytee longitudinalassociationsbetweenmarineomega3supplementusersandcoronaryheartdiseaseinaukpopulationbasedcohort